C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
4.250
+0.240 (5.99%)
At close: Nov 22, 2024, 4:00 PM
4.320
+0.070 (1.65%)
After-hours: Nov 22, 2024, 6:47 PM EST
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $300.00 million as of November 22, 2024. Its market cap has increased by 236.33% in one year.
Market Cap
300.00M
Enterprise Value
82.70M
1-Year Change
236.33%
Ranking
Category
Stock Price
$4.25
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $300.00M, a decrease of -61.18%. That is a compound annual growth rate of -20.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 292.94M | 5.21% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | 1.43B | 84.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Delcath Systems | 312.06M |
| Voyager Therapeutics | 308.91M |
| iTeos Therapeutics | 303.96M |
| COMPASS Pathways | 301.74M |
| Nautilus Biotechnology | 301.35M |
| Q32 Bio | 299.04M |
| Accolade | 297.99M |
| Vanda Pharmaceuticals | 296.79M |